bioCSL has commenced distribution of Immucor’s Capture technology platform and reagents in Australia and New Zealand. Capture is antibody detection technology used in the crossmatching of blood used for transfusion.
The technology is said to work differently from the techniques commonly used in Australia, delivering high levels of specificity and potentially reducing both the need for additional testing and delays for patients awaiting a blood transfusion. The product has a high degree of sensitivity for detection of clinically significant antibodies, providing confidence and accuracy in pre‐transfusion and prenatal screening.
Phone: 1300 369 559
Antibodies Inc recombinant antibodies
Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.
Bioss Multiplex Fluorescent IHC Staining Kit
The Bioss Multiplex Fluorescent (5 Colors) IHC Staining Kit enables the simultaneous detection of...
AdipoGen immune checkpoint reagents for immuno-oncology research
AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...
